Dominick & Dominick’s Gilead Sciences GILD Stock Holding History

Dominick & Dominick’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$1.72M	Sell	18,250 -5,835	-24%	-$603K	0.87%	27
2014 Q3	$2.56M	Sell	24,085 -1,250	-5%	-$122K	1.23%	20
2014 Q2	$2.1M	Buy	25,335 +4,815	+23%	+$375K	1.02%	22
2014 Q1	$1.45M	Buy	20,520 +15,020	+273%	+$1.18M	0.71%	38
2013 Q4	$413K	Buy	5,500 +300	+6%	+$20.9K	0.2%	128
2013 Q3	$327K	Buy	5,200 +1,000	+24%	+$59.8K	0.18%	129
2013 Q2	$215K	Buy	+4,200	New	+$219K	0.13%	150

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dominick & Dominick's GILD Position: Q4 2014 in Review

Dominick & Dominick reduced its Gilead Sciences (GILD) stake by 24% in Q4 2014, selling an estimated $603K and leaving 18,250 shares worth $1.72M. The position accounts for 0.87% of the portfolio, ranked #27.

Dominick & Dominick first reported a position in GILD in Q2 2013 and has held it in 7 quarters since. The position peaked at $2.56M in Q3 2014. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

Dominick & Dominick held 18,250 shares of Gilead Sciences worth $1.72M as of Q4 2014.
Dominick & Dominick sold 5,835 Gilead Sciences shares in Q4 2014, an estimated $603K.
Gilead Sciences made up 0.87% of Dominick & Dominick's portfolio in Q4 2014, its #27 holding.
Dominick & Dominick first reported a position in Gilead Sciences in Q2 2013 and has held it in 7 quarters since.
Dominick & Dominick's Gilead Sciences position peaked at $2.56M in Q3 2014.
1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Dominick & Dominick's 13F filing for Q4 2014, filed 22 Jan 2015.